Biotechnology News

FDA’s Rare Disease Evidence Principles (RDEP) process aims to provide greater speed and predictability in the review of therapies for rare diseases with significant unmet medical need Acceptance...

Establishes strategic commercial reach across the Middle East and North Africa, advancing Ocugen’s goal of enabling global patient access to potentially transformational gene therapiesExpands access...

AVT29 submitted to the European Medicines Agency as a line extension to the existing marketing authorization for Mynzepli® (aflibercept 2 mg) High-dose aflibercept offers the potential to reduce...

REYKJAVÍK (14. október 2026) - Alvotech (NASDAQ: ALVO, ALVO SDB) og Advanz Pharma hafa lagt inn umsókn til Lyfjastofnunar Evrópu (EMA) um markaðsleyfi fyrir fyrirhugaða hliðstæðu við augnlyfið Eylea...

AVT29 submitted to the European Medicines Agency as a line extension to the existing marketing authorization for Mynzepli® (aflibercept 2 mg) High-dose aflibercept offers the potential to reduce...

Development of quantitative biomarker strategies for proteopathies through seragy’s proprietary SeRAS® technologyExpansion of the company’s laboratory and analytical capabilities with funding from...

LONDON, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Engitix Ltd., a biotechnology company pioneering extracellular matrix (ECM)-based drug discovery and development in oncology, fibrosis and...

Sapreme Therapeutics announces its lead Duchenne muscular dystrophy candidate, SPM-2551, and is presenting preclinical data at the OTS Annual Meeting.

TRexBio Announces Closing of Initial Public Offering

Collaboration will combine Zealand Pharma’s expertise in metabolic health with Generate’s proprietary generative AI platform to create multispecific drug candidates with tailored biological functions ...